A noninvasive electrical conductor designed to be attached to the scalp surface of a patient to transmit changes in the electrical potential of various areas of the brain for recording/monitoring by a connected parent device [i.e., an electroencephalograph (EE
| Company | Devices | Share |
|---|---|---|
| Rhythmlink International, Llc | 298 | 41% |
| Technomed Engineering B.V. | 188 | 26% |
| Spes Medica Spa | 41 | 6% |
| Cadwell Industries, Inc. | 32 | 4% |
| Xltek | 27 | 4% |
| Lifesync Corporation | 25 | 3% |
| Natus Manufacturing Limited | 17 | 2% |
| Dymedix Diagnostics, Inc. | 16 | 2% |
| Ambu A/S | 15 | 2% |
| Conmed Corporation | 12 | 2% |
| Nihon Kohden Corporation | 10 | 1% |
| Ives Eeg Solutions, Llc | 6 | 1% |
Company = labeler of record on GUDID. 24 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| GXY | Electrode, Cutaneous | 700 |
| GXY | ELECTRODE, CUTANEOUS | 42 |
| GXY | Electrode, cutaneous | 33 |
| GWQ | Full-montage Standard Electroencephalograph | 9 |
| OMC | Reduced- Montage Standard Electroencephalograph | 9 |
| GWF | STIMULATOR, ELECTRICAL, EVOKED RESPONSE | 8 |
Use these as the dimensions to specify in a tender line.
724 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Analytical scalp electrode, single-use", from 24 companies. The largest labeler is Rhythmlink International, Llc with 41% of records.
GXY (Electrode, Cutaneous), GXY (ELECTRODE, CUTANEOUS), GXY (Electrode, cutaneous), GWQ (Full-montage Standard Electroencephalograph)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add analytical scalp electrode, single-use to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.